HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong Lin Selected Research

UDPacetylglucosamine pyrophosphorylase

1/2020Glucosamine promotes hepatitis B virus replication through its dual effects in suppressing autophagic degradation and inhibiting MTORC1 signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong Lin Research Topics

Disease

178Neoplasms (Cancer)
11/2022 - 10/2002
44Lung Neoplasms (Lung Cancer)
03/2022 - 01/2006
35Carcinogenesis
01/2019 - 10/2004
34Infections
01/2022 - 01/2008
33Breast Neoplasms (Breast Cancer)
01/2022 - 12/2011
23Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 10/2007
22Prostatic Neoplasms (Prostate Cancer)
01/2020 - 03/2004
21Inflammation (Inflammations)
04/2022 - 09/2003
20Hepatocellular Carcinoma (Hepatoma)
01/2022 - 11/2008
15Neoplasm Metastasis (Metastasis)
01/2020 - 01/2008
10Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 07/2003
10Fibrosis (Cirrhosis)
02/2021 - 08/2005
9Glioma (Gliomas)
10/2021 - 10/2017
9Obesity
07/2021 - 09/2008
9Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 10/2005
9Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 11/2003
9Rheumatoid Arthritis
01/2020 - 01/2017
8Hypertension (High Blood Pressure)
02/2021 - 06/2006
7Chronic Hepatitis B
12/2022 - 01/2013
7Glioblastoma (Glioblastoma Multiforme)
02/2022 - 10/2017
7Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022 - 01/2013
7Syphilis
12/2021 - 01/2018
7Liver Cirrhosis (Hepatic Cirrhosis)
02/2021 - 12/2008
7Chronic Obstructive Pulmonary Disease (COPD)
01/2020 - 12/2011
6Stomach Neoplasms (Stomach Cancer)
11/2022 - 12/2012
6Body Weight (Weight, Body)
05/2022 - 12/2006
6Necrosis
01/2018 - 06/2003
6Carcinoma (Carcinomatosis)
11/2016 - 08/2005
5COVID-19
12/2022 - 01/2020
4Neurosyphilis (General Paresis of the Insane)
12/2021 - 01/2017
4Liver Neoplasms (Liver Cancer)
02/2021 - 01/2013
4Adenocarcinoma
01/2021 - 10/2004
4Ovarian Neoplasms (Ovarian Cancer)
09/2020 - 12/2010
4Alzheimer Disease (Alzheimer's Disease)
01/2020 - 12/2014
4Hepatitis B
01/2020 - 05/2009

Drug/Important Bio-Agent (IBA)

45Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2003
27Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2005
22CytokinesIBA
05/2021 - 11/2008
20DNA (Deoxyribonucleic Acid)IBA
12/2022 - 10/2002
18Pharmaceutical PreparationsIBA
12/2022 - 05/2010
18Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2020 - 01/2006
17Cisplatin (Platino)FDA LinkGeneric
09/2020 - 05/2003
15Biological ProductsIBA
06/2022 - 10/2002
15MicroRNAs (MicroRNA)IBA
01/2022 - 12/2012
14Messenger RNA (mRNA)IBA
02/2022 - 12/2006
14NF-kappa B (NF-kB)IBA
01/2011 - 06/2003
13Phosphotransferases (Kinase)IBA
01/2021 - 06/2003
12Glucose (Dextrose)FDA LinkGeneric
02/2021 - 12/2006
12CarcinogensIBA
01/2017 - 10/2002
9Small Interfering RNA (siRNA)IBA
08/2022 - 11/2006
9Insulin (Novolin)FDA Link
01/2022 - 04/2010
9TeaIBA
07/2021 - 01/2002
9LipidsIBA
02/2021 - 12/2006
9sarilumabIBA
01/2020 - 01/2017
9LigandsIBA
06/2019 - 10/2007
9AndrogensIBA
10/2018 - 02/2005
8Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 12/2002
8Interleukin-6 (Interleukin 6)IBA
07/2021 - 01/2012
8SmokeIBA
01/2020 - 01/2011
7Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2022 - 06/2009
7GemcitabineFDA Link
01/2021 - 10/2007
7Caffeine (No Doz)FDA LinkGeneric
01/2013 - 01/2002
6AntioxidantsIBA
05/2022 - 11/2008
6Estrogen ReceptorsIBA
01/2022 - 11/2012
6Long Noncoding RNAIBA
10/2021 - 06/2014
6Mitogen-Activated Protein KinasesIBA
01/2019 - 06/2003
6Transcription Factors (Transcription Factor)IBA
01/2019 - 04/2008
6LuteolinIBA
07/2018 - 05/2007
6Tocopherols (Tocopherol)IBA
01/2018 - 03/2011
6Paclitaxel (Taxol)FDA LinkGeneric
12/2016 - 08/2003
6Caspase 3 (Caspase-3)IBA
01/2015 - 01/2002
6Atorvastatin (Lipitor)FDA Link
06/2014 - 09/2007
6Celecoxib (Celebrex)FDA Link
06/2014 - 10/2004
6Reactive Oxygen Species (Oxygen Radicals)IBA
02/2014 - 07/2004
6FlavonoidsIBA
08/2012 - 05/2007
5Peptides (Polypeptides)IBA
01/2022 - 10/2017
5AntibodiesIBA
12/2021 - 01/2008
5Circular RNAIBA
08/2021 - 01/2018
5Antirheumatic Agents (DMARD)IBA
01/2020 - 01/2017
5Metformin (Glucophage)FDA LinkGeneric
01/2020 - 08/2015
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 05/2008
5AntigensIBA
01/2020 - 01/2008
5Matrix Metalloproteinases (MMPs)IBA
01/2018 - 08/2003
5Therapeutic UsesIBA
01/2018 - 10/2002
5Mucin-1 (CA 15-3 Antigen)IBA
10/2017 - 01/2012
5wogoninIBA
06/2017 - 04/2011
5RamucirumabIBA
02/2017 - 06/2015
4Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2022 - 11/2017
4VaccinesIBA
01/2022 - 01/2020
4Cadherins (E-Cadherin)IBA
02/2021 - 11/2005
4AdipokinesIBA
02/2021 - 06/2012
4Hormones (Hormone)IBA
01/2021 - 11/2012
4RNA (Ribonucleic Acid)IBA
09/2020 - 08/2015
4Protein CIBA
03/2020 - 05/2008
4EnzymesIBA
01/2020 - 01/2015

Therapy/Procedure

69Therapeutics
12/2022 - 05/2003
16Drug Therapy (Chemotherapy)
11/2022 - 10/2002
10Radiotherapy
02/2019 - 11/2003
6Injections
06/2014 - 03/2004
5Conservative Treatment
01/2018 - 07/2008